2009 H1N1 pandemic update : pneumococcal vaccination recommended to help prevent secondary infections

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Monday, November 16, 2009, 13:51 EST (01:51 PM EST)
  
  CDCHAN-00301-2009-11-16-ADV-N
  
  Summary of recommendations: CDC's Advisory Committee on Immunization Practices (ACIP) recommends a single dose of pneumococcal polysaccharide vaccine (PPSV) for all people 65 years of age and older and for persons 2 through 64 years of age with certain high-risk conditions. Among those with high-risk conditions for pneumococcal disease, most are also at high risk for severe complications from influenza. Special emphasis should be placed on vaccinating adults under 65 years of age who have established high-risk conditions for pneumococcal disease; PPSV coverage among this group is low and this group may be more likely to develop secondary bacterial pneumonia after an influenza infection. All children younger than 5 years of age should continue to receive pneumococcal conjugate vaccine (PCV7) according to existing recommendations.
  
  
• Subjects:
  Influenza, Human/prevention & Control Influenza A Virus, H1N1 Subtype Pandemics Pneumococcal Infections/prevention & Control Pneumococcal Vaccines/administration & Dosage
• Source:
  HAN ; 301
• Series:
  Health Alert Network
• Document Type:
  HAN Health Advisory
• Place as Subject:
  United States
• Pages in Document:
  4 unnumbered pages
• Issue:
  301
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:496c27998ad9c08daa0d06bd4cb851b7e8777ca905c1621f3d8bcef40fdda1f27f513b872cc60639487f83c04349add9675e1220bab5029166c0aa7466562b5f
• Download URL:
  https://stacks.cdc.gov/view/cdc/25212/cdc_25212_DS1.pdf
• File Type:
  [PDF - 751.59 KB ]